• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Clinical and Experimental Investigations >Outcomes of modified deep scleral trabeculectomy surgery under anterior chamber maintainer
【24h】

Outcomes of modified deep scleral trabeculectomy surgery under anterior chamber maintainer

机译：前房保持器改良深巩膜小梁切除术的结果

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: To evaluate patients monitored for glaucoma and operated with trabeculectomy combined with deep sclerectomy under an anterior chamber maintainer. Methods: In this retrospective study, fifteen eyes of 15 patients diagnosed with primary open angle glaucoma (POAG) who show up regularly for follow-up examinations between April 2006 and May 2010 were included in this study. Pre-operative/post-operative intraocular pressure (IOP) and the number of antiglaucomatous medications were evaluated. Results: The mean age was 64.6 ± 11.4 (33-80) years and the mean follow-up period was 22.4 ± 16.2 months (6-55). The mean pre-operative IOP was 24.6 ± 8.0 (12-40 mmHg), and the mean cup/disc (c/d) ratio was 0.71 ± 0. 25. According to the Hodapp classification, the mean damage in the visual field was 2.1 ± 0.9. Mean post-operative IOP at months 1, 12, and 24 was 13.2 ± 3.4, 13.6 ± 4.6 and 13.8 ± 2.8 mmHg, respectively. The average number of pre-operative antiglaucomatous medications was 3.1 whereas the average numbers of post-operative antiglaucomatous medications were 1.8, 0.6 and 0.8 respectively. Conclusion: Modified trabeculectomy has low rates of complication and results in a significant decrease in postoperative IOP, as well as the number of antiglaucomatous medications used.
机译：目的：评估在前房保持器的情况下接受青光眼监测并经小梁切除术联合深层巩膜切除术的患者。方法：在这项回顾性研究中，纳入了2006年4月至2010年5月期间定期进行随访检查的15例确诊为原发性开角型青光眼（POAG）的患者的15只眼。评估术前/术后眼内压（IOP）和抗青光眼药物的数量。结果：平均年龄为64.6±11.4（33-80）岁，平均随访时间为22.4±16.2个月（6-55）。术前平均眼压为24.6±8.0（12-40 mmHg），平均杯/盘（c / d）比为0.71±0。25.根据Hodapp分类，视野中的平均损伤为2.1±0.9。第1、12和24个月的平均术后IOP分别为13.2±3.4、13.6±4.6和13.8±2.8 mmHg。术前抗青光眼药物的平均数量为3.1，而术后抗青光眼药物的平均数量分别为1.8、0.6和0.8。结论：改良小梁切除术并发症发生率低，导致术后IOP显着降低，以及使用的抗青光眼药物数量减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号